Physician

Cory Halliburton, M.D.

According to 2025 Medicare claims, Cory Halliburton, M.D. (NPI: 1083767685) practices gastroenterology in the Burlington-South Burlington, VT market, with the plurality of this provider's patient population coming from Chittenden, VT. This provider's primary affiliated billing organization is ASSOCIATES IN GASTROENTEROLOGY, PLLC (NPI: 1346496783; TIN: 261603320) and primary practice location at 05446-4460.

Halliburton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 305 traditional Medicare patients, billed 2,038 HCPCS/CPT codes, and received $86,709 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 474 prescription claims across 216 beneficiaries totaling $115,746 in drug costs, led by Mesalamine (Mesalamine). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $432,195 to $115,746. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$43K$87K2015 Medicare payment: $56,249 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $65,488 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $57,881 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $56,296 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $63,356 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $65,317 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $70,328 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $54,093 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $55,140 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $86,709 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015261408$56,249
2016332522$65,488
2017299657$57,881
2018313674$56,296
2019322583$63,356
2020330474$65,317
2021364519$70,328
2022283399$54,093
2023284394$55,140
20243052,038$86,709

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$216K$432K2015 Drug cost: $432,195 (USD; Tot_Drug_Cst)2016 Drug cost: $240,309 (USD; Tot_Drug_Cst)2017 Drug cost: $245,790 (USD; Tot_Drug_Cst)2018 Drug cost: $267,748 (USD; Tot_Drug_Cst)2019 Drug cost: $161,208 (USD; Tot_Drug_Cst)2020 Drug cost: $273,485 (USD; Tot_Drug_Cst)2021 Drug cost: $167,086 (USD; Tot_Drug_Cst)2022 Drug cost: $102,461 (USD; Tot_Drug_Cst)2023 Drug cost: $292,010 (USD; Tot_Drug_Cst)2024 Drug cost: $115,746 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015158425$432,195
2016183516$240,309
2017181544$245,790
2018174480$267,748
2019206444$161,208
2020197446$273,485
2021266533$167,086
2022143338$102,461
2023162364$292,010
2024216474$115,746

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare138139$194
G0121Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk2424$171
G0105Colorectal cancer screening; colonoscopy on individual at high risk3434$170
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more3443$124
43239Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope4848$84

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MesalamineMesalamine291,890$22,776
Mesalamine ErMesalamine22780$5,898
ClenpiqSod Picosulf/Mag Ox/Citric Ac2529$4,278
AzathioprineAzathioprine332,190$1,805
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl75118$1,286

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Cory Halliburton, M.D.?

Tedicare shows public-source Medicare data for Cory Halliburton, M.D. (NPI 1083767685), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Cory Halliburton, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Cory Halliburton, M.D.?

Cory Halliburton, M.D. is linked to ASSOCIATES IN GASTROENTEROLOGY, PLLC (billing NPI 1346496783) in the available physician profile data.

Does Cory Halliburton, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.